Page 579 - Withrow and MacEwen's Small Animal Clinical Oncology, 6th Edition
P. 579

CHAPTER 25  Tumors of the Skeletal System  557


            92.   Barger AM, Fan TM, de Lorimier LP, et al.: Expression of receptor     114.   Boston SE, Ehrhart NP, Dernell WS, et al.: Evaluation of survival
               activator of nuclear factor kappa-B ligand (RANKL) in neoplasms   time in dogs with stage III osteosarcoma that undergo treatment;90
               of dogs and cats, J Vet Intern Med 21:133–140, 2007.  cases (1985-2004), J Am Vet Med Assoc 228:1905–1908, 2006.
  VetBooks.ir   93.   Lana SE, Ogilvie GK, Hansen RA, et al.: Identification of matrix     115.   Giuliano AE, Feig S, Eilber FR: Changing metastatic patterns of
                                                                     osteosarcoma, Cancer 54:2160–2164, 1984.
               metalloproteinases in canine neoplastic tissue, Am J Vet Res 61:111–
               114, 2000.
            94.   Schmit JM, Pondenis HC, Barger AM, et al.: Cathepsin K expres-    116.   Bacci G, Avella M, Picci P, et al.: Metastatic patterns in osteosar-
                                                                     coma, Tumori 74:421–427, 1988.
               sion and activity in canine osteosarcoma, J Vet Intern Med 26:126–    117.   Moore GE, Mathey WS, Eggers JS, et al.: Osteosarcoma in adjacent
               134, 2012.                                            lumbar vertebrae in a dog, J Am Vet Med Assoc 217(1008):1038–
            95.   Marley  K, Bracha S, Seguin B: Osteoprotegerin  activates osteo-  1040, 2000.
               sarcoma cells that co-express RANK and RANKL,  Exp Cell Res     118.   Talbott JL, Boston SE, Milner RJ, et al.: Retrospective evaluation of
               338:32–38, 2015.                                      whole body computed tomography for tumor staging in dogs with
            96.   Neumann ZL, Pondenis HC, Masyr A, et al.: The association of   primary appendicular osteosarcoma, Vet Surg 46:75–80, 2017.
               endothelin-1 signaling with bone alkaline phosphatase expression     119.   Oblak ML, Boston SE, Woods JP, et al.: Comparison of concurrent
               and protumorigenic activities in canine osteosarcoma, J Vet Intern   imaging modalities for staging of dogs with appendicular primary
               Med 29:1584–1594, 2015.                               bone tumours, Vet Comp Oncol 13:28–39, 2015.
            97.   Shor S, Fadl-Alla BA, Pondenis HC, et al.: Expression of nociceptive     120.   Sivacolundhu RK, Runge JJ, Donovan TA, et al.: Ulnar osteosar-
               ligands in canine osteosarcoma, J Vet Intern Med 29:268–275, 2015.  coma in dogs;30 cases (1992-2008), J Am Vet Med Assoc 243:96–
            98.   Khanna  C, Wan  X, Bose S, et  al.: The membrane-cytoskeleton   101, 2013.
               linker  ezrin  is  necessary  for  osteosarcoma  metastasis,  Nat  Med     121.   Montinaro V, Boston SE, Buracco P, et al.: Clinical outcome of
               10:182–186, 2004.                                     42 dogs with scapular tumors treated by scapulectomy;a Veterinary
            99.   Fan TM, Barger AM, Fredrickson RL, et al.: Investigating CXCR4   Society of Surgical Oncology (VSSO) retrospective study (1995-
               expression in canine appendicular osteosarcoma, J Vet Intern Med   2010), Vet Surg 42:943–950, 2013.
               22:602–608, 2008.                                   122.   Straw RC, Powers BE, Klausner J, et al.: Canine mandibular osteo-
             100.   Byrum ML, Pondenis HC, Fredrickson RL, et al.: Downregulation   sarcoma; 51 cases (1980-1992), J Am Anim Hosp Assoc 32:257–262,
               of CXCR4 expression and functionality after zoledronate exposure   1996.
               in canine osteosarcoma, J Vet Intern Med 30:1187–1196, 2016.    123.   Dickerson ME, Page RL, LaDue TA, et al.: Retrospective analysis
             101.   Barger A, Graca R, Bailey K, et al.: Use of alkaline phosphatase   of axial skeleton osteosarcoma in 22 large-breed dogs, J Vet Intern
               staining to differentiate canine osteosarcoma from other vimentin-  Med 15:120–124, 2001.
               positive tumors, Vet Pathol 42:161–165, 2005.       124.   Selmic  LE, Lafferty MH, Kamstock DA, et  al.: Outcome and
             102.   Neihaus SA, Locke JE, Barger AM, et al.: A novel method of core   prognostic factors for osteosarcoma of the maxilla, mandible, or
               aspirate cytology compared to fine-needle aspiration for diagnosing   calvarium in dogs; 183 cases (1986-2012),  J Am Vet Med Assoc
               canine osteosarcoma, J Am Anim Hosp Assoc 47:317–323, 2011.  245:930–938, 2014.
             103.   Britt T, Clifford C, Barger A, et al.: Diagnosing appendicular osteo-    125.   Coyle VJ, Rassnick KM, Borst LB, et al.: Biological behaviour of
               sarcoma with ultrasound-guided fine-needle aspiration; 36 cases,    canine mandibular osteosarcoma. A retrospective study of 50 cases
               J Small Anim Pract 48:145–150, 2007.                  (1999-2007), Vet Comp Oncol 13:89–97, 2015.
             104.   Kirpensteijn J, Kik M, Rutteman GR, et al.: Prognostic significance     126.   Amsellem PM, Selmic LE, Wypij JM, et al.: Appendicular osteo-
               of a new histologic grading system for canine osteosarcoma, Vet   sarcoma in small-breed dogs; 51 cases (1986-2011), J Am Vet Med
               Pathol 39:240–246, 2002.                              Assoc 245:203–210, 2014.
             105.   Schott CR, Tatiersky LJ, Foster RA, et al.: Histologic grade does     127.   Boulay JP, Wallace LJ, Lipowitz AJ: Pathological fracture of long
               not predict outcome in dogs with appendicular osteosarcoma   bones in the dog, J Am An Hosp Assoc 23:297–303, 1987.
               receiving the standard of care, Vet Pathol 55:202–211, 2018.    128.   Mazzaferro EM, Hackett TB, Stein TP, et al.: Metabolic alterations
             106.   O’Donoghue  LE,  Ptitsyn  AA,  Kamstock  DA,  et  al.:  Expression   in dogs with osteosarcoma, Am J Vet Res 62:1234–1239, 2001.
               profiling in canine osteosarcoma; identification of biomarkers and     129.   Story  AL, Boston SE, Kilkenny JJ, et  al.: Evaluation of weight
               pathways associated with outcome, BMC Cancer 10:506, 2010.  change during carboplatin  therapy  in  dogs with appendicular
             107.   Bhandal J, Boston SE: Pathologic fracture in dogs with suspected or   osteosarcoma, J Vet Intern Med 31:1159–1162, 2017.
               confirmed osteosarcoma, Vet Surg 40:423–430, 2011.    130.   Kazmierski KJ, Ogilvie GK, Fettman MJ, et al.: Serum zinc, chro-
             108.   Kim MS, Lee SY, Lee TR, et al.: Prognostic effect of pathologic   mium, and iron concentrations in dogs with lymphoma and osteo-
               fracture in localized osteosarcoma; a cohort/case controlled study at   sarcoma, J Vet Intern Med 15:585–588, 2001.
               a single institute, J Surg Oncol 100:233–239, 2009.    131.   Wrigley RH: Malignant versus nonmalignant bone disease, Vet Clin
             109.   Ebeid W, Amin S, Abdelmegid A: Limb salvage management of   North Am Small Anim Pract 30:315–347, 2000. vi-vii.
               pathologic fractures of primary malignant bone tumors,  Cancer     132.   Charney  VA,  Miller  MA,  Heng HG,  et  al.: Skeletal  metastasis
               Control 12:57–61, 2005.                               of canine urothelial carcinoma; pathologic and computed tomo-
             110.   Bacci G, Ferrari S, Longhi A, et al.: Nonmetastatic osteosarcoma   graphic features, Vet Pathol 54:380–386, 2017.
               of the extremity with pathologic fracture at presentation;local and     133.   Reinhardt S, Stockhaus C, Teske E, et al.: Assessment of cytological
               systemic control by amputation or limb salvage after preoperative   criteria for diagnosing osteosarcoma in dogs, J Small Anim Pract
               chemotherapy, Acta Orthop Scand 74:449–454, 2003.     46:65–70, 2005.
             111.   Boston SE, Vinayak A, Lu X, et al.: Outcome and complications in     134.   Samii VF, Nyland TG, Werner LL, et al.: Ultrasound-guided fine-
               dogs with appendicular primary bone tumors treated with stereo-  needle aspiration biopsy of bone lesions; a preliminary report, Vet
               tactic radiotherapy and concurrent surgical stabilization, Vet Surg   Radiol Ultrasound 40:82–86, 1999.
               46:829–837, 2017.                                   135.   Ehrhart N: Principles of tumor biopsy, Clin Tech Small Anim Pract
             112.   Covey JL, Farese JP, Bacon NJ, et al.: Stereotactic radiosurgery and   13:10–16, 1998.
               fracture fixation in 6 dogs with appendicular osteosarcoma,  Vet     136.   Mankin  HJ,  Lange TA, Spanier SS: The hazards of biopsy in
               Surg 43:174–181, 2014.                                patients with malignant primary bone and soft-tissue tumors,
             113.   Hillers KR, Dernell WS, Lafferty MH, et al.: Incidence and prog-  J Bone Joint Surg Am 64:1121–1127, 1982.
               nostic importance of lymph node metastases in dogs with appen-    137.   de Santos LA, Murray JA, Ayala AG: The value of percutaneous
               dicular osteosarcoma; 228 cases (1986-2003), J Am Vet Med Assoc   needle biopsy in the management of primary bone tumors, Cancer
               226:1364–1367, 2005.                                  43:735–744, 1979.
   574   575   576   577   578   579   580   581   582   583   584